Quarterly report pursuant to sections 13 or 15(d)

Subsequent Events (Details Narrative)

v2.4.0.8
Subsequent Events (Details Narrative) (USD $)
0 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended
Feb. 29, 2012
Jul. 01, 2013
Dec. 31, 2013
Purchase Agreement [Member]
Dec. 31, 2013
Merger Agreement [Member]
Dec. 31, 2013
Purchase Agreement Two [Member]
Dec. 31, 2013
]Purchase Agreement Three [Member]
Jan. 09, 2014
Subsequent Event [Member]
Jan. 10, 2014
Subsequent Event [Member]
Feb. 10, 2014
Subsequent Event [Member]
Purchase Agreement [Member]
Feb. 07, 2014
Pharma [Member]
Subsequent Event [Member]
Jan. 10, 2014
Pharma [Member]
Subsequent Event [Member]
Feb. 07, 2014
Placement Agent [Member]
Subsequent Event [Member]
Dec. 31, 2013
Highline Research Advisors LLC [Member]
Dec. 31, 2013
Website And Investment Related Services [Member]
Dec. 31, 2013
AAK Ventures, LLC [Member]
Issuance of common shares for cash $ 33,000                 $ 3,923,100          
Issuance of common shares for cash, Shares 330,000                 6,276,960 30,000,000 6,276,960 750,000    
Issuance of warrants during the period     700,000             6,276,960   8,537,405   250,000  
Issuance of warrants price per share                   $ 0.625   $ 0.625 $ 0.625 $ 0.625  
Common stock issuance price per share                       $ 0.625      
Number of Common stock shares acquired from related party                     66.67        
Percentage of shares issued and outstanding   87.00%                 40.00%        
Percentage of shares owned by holding               0.39     0.60        
Number authorized stock dividend for shares             3.4                
Stock issued during period for agreement     30,000,000 3,229,093                      
Warrants expiration period         3 years 3 years     2 years            
Issuance of stock under purchase agreement         100,000       500,000            
Issuance of stock under purchase agreement price less than per share                 $ 1.25            
Stock issued during period at initial tranche         500,000                    
Percentage of shares at initial tranche         140.00%                    
Stock issued during period at second tranche           100,000                  
Percentage of shares at second tranche           140.00%                  
Restricted shares of common stock                             39,820,000
Percentage of cancellation shares                             52.00%
Number of cancellation shares for free tradable                             963,604.4